Recurrent metastatic anal cancer treated with modified paclitaxel, ifosfamide, and cisplatin and third-line mitomycin/cetuximab

Authors

Keywords

Journal

Volume 21, Issue 3, Pages 232-237

Publisher

SAGE Publications

Online

2014-03-14

DOI

10.1177/1078155214526268

References

View 4 related references

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now